Our results agree with previous reports of enhanced glycolysis in MASLD due to increased mRNA levels of glycolytic enzymes (HK2 and PKM2) [68] and the augmented liver glucose phosphorylating activity of hexokinase [69]. This evidence concerns the gene HK2 and metabolic dysfunction-associated steatotic liver disease.